Welcome to our dedicated page for Lifestance Health Group news (Ticker: LFST), a resource for investors and traders seeking the latest updates and insights on Lifestance Health Group stock.
LifeStance Health Group, Inc. (Nasdaq: LFST) is a mental healthcare company that focuses on outpatient services and regularly issues news and updates about its operations. The company describes itself as one of the nation’s largest providers of virtual and in-person outpatient mental healthcare for children, adolescents and adults, and its news flow reflects both its clinical focus and its role as a public company.
On this page, readers can find news items such as quarterly earnings results, financial outlooks and operational metrics. LifeStance’s earnings releases discuss topics like revenue, visit volumes, clinician base, Center Margin, Adjusted EBITDA and Free Cash Flow, along with commentary from management on business performance and guidance. These updates provide insight into how the company’s outpatient mental health services translate into financial and operating results.
LifeStance also publishes announcements about participation in healthcare investor conferences hosted by organizations such as UBS, Morgan Stanley and Goldman Sachs. These releases typically include details about presentation dates, times and webcast availability, and they underscore the company’s ongoing engagement with the investment community.
In addition, LifeStance issues news related to corporate governance, including changes to its board of directors, and survey-based research on mental health topics. For example, the company has shared survey findings on how the holiday season affects mental health, addressing themes like seasonal stress, social pressure, loneliness and family dynamics. Together, these news items offer a view into LifeStance’s financial performance, strategic priorities and perspective on mental health trends.
Investors, analysts and others interested in LFST can use this news feed to follow the company’s regular earnings communications, conference appearances, governance updates and mental health surveys in one place.
LifeStance Health Group, Inc. (NASDAQ: LFST), a leading provider of outpatient mental health care in the United States, has announced its plans to release second quarter 2024 earnings before the market opens on Thursday, August 8, 2024. The company will host a live earnings conference call on the same day at 8:30 a.m. Eastern Time to discuss the results.
Interested parties can participate in the call by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and using the conference ID 1488997. A real-time audio webcast will be available on the LifeStance Investor Relations website, where related materials will be posted prior to the call. A replay of the webcast will also be accessible after the conference call concludes.
LifeStance Health Group (NASDAQ: LFST), a leading provider of outpatient mental health care in the U.S., announced its participation in two upcoming investor conferences. CFO Dave Bourdon and VP of Finance and Investor Relations Monica Prokocki will attend the UBS Healthcare Services Cape Cod Summit on June 4, 2024, in Chatham, MA, and the Goldman Sachs 45th Annual Healthcare Conference on June 10, 2024, in Miami Beach, FL. While the Cape Cod event will not include presentations, the Goldman Sachs conference will feature a presentation at 10:00 a.m. ET, which will be webcast live and later available for replay on LifeStance’s Investor Relations website.
LifeStance Health Group announced the pricing of a secondary public offering of 20,000,000 shares at $6.25 per share. The underwriters have a 30-day option to purchase an additional 3,000,000 shares. Proceeds will go to the selling stockholders, with none to LifeStance. The offering is expected to close by May 24, 2024, subject to customary conditions. The transaction is facilitated by major financial institutions including Morgan Stanley and Goldman Sachs. The shelf registration statement was filed with the SEC and became effective on May 21, 2024.
LifeStance Health Group announced a secondary public offering of 20 million shares of common stock by certain stockholders. The underwriters are given a 30-day option to purchase an additional 3 million shares. LifeStance will not sell any shares or receive any proceeds from this offering. The offering is made under a shelf registration statement filed with the SEC on May 21, 2024. Morgan Stanley, Goldman Sachs & TPG Capital are the underwriters. The prospectus is available on the SEC's website.
LifeStance Health Group, Inc. (Nasdaq: LFST) reported strong financial results for Q1 2024, with a revenue increase of 19% to $300.4 million, driven by higher visit volumes and improved revenue per visit. The clinician base also grew by 15%, reaching 6,866 clinicians. The company posted a net loss of $21.1 million, attributed to stock-based compensation, and an Adjusted EBITDA of $27.7 million. LifeStance reiterated its full-year revenue guidance of $1.19 billion to $1.24 billion, raising Center Margin expectations to $353 to $373 million, and Adjusted EBITDA to $88 to $98 million. The company also expects to maintain positive Free Cash Flow for the year.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.